Search results for "slas europe 2018"

Bottoms are 60% thinner than conventional polystyrene plates, resulting in lower background fluorescent and enabling readings down to 340nm Designed to reduce well-to-well crosstalk during luminescent assays Can be used for both top and bottom reading instruments Not treated (or medium binding) polystyrene surface is hydrophobic in nature and binds biomolecules through passive interactions Is suitable primarily for the i…

Transition interval: pH 1.4 - 2.4 (colorless - rose fluorescence)Formula: C20H6Br2N2Na2O9M: 624.08 g/molCAS-No.: 548-24-3HS-No.: 32041200EC-No.: 208-943-1Storage: RTLGK: 10 - 13Specification: Assay (photometr.): min. 90 %

usage: Ready-to-use indicator solution in 96 % ethanolHS-No.: 38220000EC-No.: 201-004-7Storage: RTLGK: 3 ADisposal: 1R: 11S: 7/9-16hazardidentification: highly flammableClass/PG: 3/IIUN-No.: UN1993

Eftilagimod alpha, a soluble LAG-3 fusion protein is a first-in-class antigen presenting cell activator currently being explored in cancer and infectious disease

Institut Curie is one of an increasing number of major European cancer centers to become a co-validation partner for the new NGS-based MammaPrint BluePrint Kit

Origin: from Rhamnus frangulaFormula: C15H10O5M: 270.23 g/molCAS-No.: 518-82-1HS-No.: 29146990EC-No.: 208-258-8Storage: 2-8°CLGK: 10 - 13R: 22S: 22-45hazardidentification: harmfulSpecification: Assay (HPLC): min. 99 %

Dr Emilio Diez-Monedero explains the current approach to molecular drug discovery and gives SelectScience a sneak peek into the SLAS Spanish Drug Discovery Network Meeting

European launch of the new CE marked ipsogen CALR RGQ PCR Kit to improve MPN diagnosis for leukemia patients, in line with latest WHO recommendations and clinical guidelines

Chemomab’s CM-101 is a first-in-class, CCL24-neutralizing monoclonal antibody expected to enter a Phase 2 clinical trial in SSc patients early next year

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Discovering new mathematical means of helping regulators and business manage and police Artificial Intelligence systems

Comparison of Custom Designed KASP and Taqman Genotyping Assays for A Rare Genetic Variant Identified Through Resequencing GWAS Loci